News Features Reimbursement Issues Seem to Be Holding Renal Denervation Back Todd Neale December 19, 2024
News Features The Promise of Pulsed-Field Ablation: Cautious Optimism Amid Some Unknowns Todd Neale March 29, 2024
News Features Expired Cardiac Devices May Do Global Good, but Safety Unknown Yael L. Maxwell August 26, 2021
News Features Virtual Training Booms as COVID-19 Limits In-Person Proctoring, Observation Yael L. Maxwell April 21, 2021
News Features ‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19 Michael O'Riordan April 07, 2020
News Features Year in Review: Low-Risk TAVR Trials Big in 2019, but QoL Data Impresses, Too Michael O'Riordan December 18, 2019
News Features Catheter Kerfuffle: How Concerning Is Off-Label Use in Stroke Interventions? Todd Neale June 21, 2017
News Features Stents as Essential Medicine: India’s Cap on Stent Prices Could Have Ripples Around the Globe Shelley Wood May 05, 2017
News Features The Prickly Problem of Permanent Pacing After TAVR: One Hospital Pitches a Protocol Michael O'Riordan January 24, 2017
News Features The Bioresorbable Stent Story So Far: What Promise? What Price? Michael O'Riordan August 17, 2016
News Features Digesting the Valve Degeneration Data: One Month Later, Reactions From TAVR Experts Range From ‘Disturbed’ to Indifferent Caitlin E. Cox June 17, 2016
News Features Future of Renal Denervation May Hinge on a Handful of Small Studies Todd Neale February 14, 2016
News Features Las Aprobaciones de los Balones Recubiertos de Fármacos ‘Cambiarán’ el Tratamiento de la EAP L.A. McKeown January 28, 2015
News Features Drug-Coated Balloon Approvals Mark ‘Sea Change’ for Treatment of PAD L.A. McKeown January 28, 2015